Psychiatry & Behavioral Health
Major Depressive Disorder (MDD)
Major Depressive Disorder (MDD) is one of the most common mental health conditions worldwide, affecting mood, behavior, sleep, and daily functioning. CenExel partners with sponsors to advance innovative MDD treatments through scientifically driven clinical research, experienced investigators, and diverse patient populations.
Studies Conducted
0
+
Trial Participants
0
+
Active Sites
0
+
Overview
Advancing Clinical Research for Major Depressive Disorder
CenExel’s MDD research sites specialize in evaluating novel therapies designed to improve outcomes for individuals living with depression. Our experienced psychiatric investigators conduct studies ranging from early-phase safety trials to large-scale outpatient depression programs.
With access to broad and diverse patient populations, CenExel delivers efficient enrollment, high-quality data collection, and patient-centered care throughout every stage of the clinical trial process.
Conditions Covered
Major Depressive Conditions We Research
CenExel supports a wide range of depressive disorder research programs across multiple patient populations and symptom profiles.
- Major Depressive Disorder (MDD)
- Treatment-Resistant Depression (TRD)
- Postpartum Depression (PPD)
- Adolescent Depression
- Persistent Depressive Disorder
- Depression with Anxiety
- Bipolar Depression
- Geriatric Depression
Our Approach
Why Sponsors Choose CenExel for MDD Research
CenExel combines scientific expertise, patient-focused engagement strategies, and operational excellence to support successful depression clinical trials.
01
Expert Psychiatric Investigators
Experienced clinicians lead studies focused on depressive disorders across diverse patient populations.
02
Rapid Patient Enrollment
Advanced recruitment systems help accelerate enrollment timelines for MDD and TRD studies.
03
Diverse Study Populations
Access to broad demographic populations improves representation and study quality.
04
High-Quality Data Collection
Standardized research operations support consistent, reliable clinical outcomes.
Phase Coverage
Supported Depression Trial Phases
CenExel supports psychiatric and depression-related clinical studies from first-in-human through Phase IV post-marketing programs.
Active across all phases
- Phase I
- Phase II
- Phase III
- Phase IV
Our psychiatric research network supports biomarker studies, digital therapeutics, outpatient depression trials, and treatment-resistant depression programs with experienced operational oversight.
MDD Task Force
CenExel’s MDD task force supports sponsors with experienced psychiatric investigators, centralized recruitment strategies, and scalable outpatient research capabilities across multiple locations.
Active Sites
18 Sites
CenExel Phoenix
CenExel Anaheim
CenExel Atlanta
CenExel Marlton
CenExel Gaithersburg
